Abstract
The aim of this study was to test the capacity of the novel adjuvant OM-174, a lipid A analog, to induce the migration and the maturation of murine dendritic cells (DC) in vivo, a step which is considered as the initiation of the adaptive immune response. BALB/c mice were injected intravenously or subcutaneously with OM-174. The spleen and popliteal lymph nodes were harvested, and analyzed for DC localization and phenotype. The data presented here clearly show that, OM-174 induces the migration of DC from the periphery to the T cell areas of lymphoid organs, and their maturation into cells expressing high levels of MHC class II and co-stimulatory molecules, with a potency close to that of Escherichia coli lipopolysaccharide (LPS).
MeSH terms
-
Adjuvants, Immunologic / administration & dosage
-
Adjuvants, Immunologic / pharmacology*
-
Animals
-
Antigen-Presenting Cells / classification
-
Antigen-Presenting Cells / cytology
-
Antigen-Presenting Cells / drug effects
-
Antigen-Presenting Cells / immunology
-
Cell Differentiation / drug effects
-
Cell Movement / drug effects
-
Dendritic Cells / classification
-
Dendritic Cells / cytology*
-
Dendritic Cells / drug effects*
-
Dendritic Cells / immunology
-
Female
-
Injections, Intravenous
-
Injections, Subcutaneous
-
Langerhans Cells / classification
-
Langerhans Cells / cytology
-
Langerhans Cells / drug effects
-
Langerhans Cells / immunology
-
Lipopolysaccharides / administration & dosage
-
Lipopolysaccharides / pharmacology*
-
Lymph Nodes / cytology
-
Lymph Nodes / drug effects
-
Lymph Nodes / immunology
-
Mice
-
Mice, Inbred BALB C
-
Spleen / cytology
-
Spleen / drug effects
-
Spleen / immunology
Substances
-
Adjuvants, Immunologic
-
Lipopolysaccharides
-
defoslimod